Suppression of mutant Kirsten-RAS (KRASG12D)-driven pancreatic carcinogenesis by dual-specificity MAP kinase phosphatases 5 and 6. (2022)
Attributed to:
Regulation of the oncogenic potential of signalling through the Ras/ERK pathway by dual-specificity phosphatase 5
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41388-022-02302-0
PubMed Identifier: 35418690
Publication URI: http://europepmc.org/abstract/MED/35418690
Type: Journal Article/Review
Volume: 41
Parent Publication: Oncogene
Issue: 20
ISSN: 0950-9232